In summary, functional core–shell nanoparticles were
synthesized by a microwave assisted route, enabling rapid
and reproducible synthesis of well-defined Fe3O4@SiO2@NH2
nanoparticles. They could be decorated on the surfaces with
Rink-amide linkers to make the Fe3O4@SiO2@NH-(bAla)2-
Rink core–shell particles applicable as colloidal supports for
peptide synthesis. A tetrapeptide model and a potentially
bioactive undecapeptide were accessed, both exhibiting excellent
purities as isolated crude products. As the magnetic sedimenta-
tion proved to be an effective isolation step that might be easily
automatized and microwave assisted particle synthesis can be
combined with continuous flow reactors, large scale automated
peptide synthesis on colloidal supports can be foreseen.
We acknowledge Prof. Rademann, R. Wendt and F. Fischer
(HU) for their contribution, M. Suess (ETH) for TEM and
¨
CEM for helpful assistance. HGB acknowledges support by
German Research Council DFG (CORE BO1762/4-1).
Fig. 3 HPLC-trace and ESI-MS spectrum of synthesized peptide
H2N–Phe-Lys-Leu-Gly–CONH2 (gradient: 3–50% MeCN, RP-C18-
column, l = 210 nm). Mass of peptide found with 95% purity.
Notes and references
1 (a) R. B. Merrifield, J. Am. Chem. Soc., 1963, 85, 2149;
(b) R. B. Merrifield, Angew. Chem., 1985, 97, 801.
2 (a) T. Kimmerlin and D. Seebach, J. Pept. Res., 2005, 65, 229;
(b) A. R. Mitchell, Biopolymers, 2008, 90, 175; (c) B. L. Nilsson,
M. B. Soellner and R. T. Raines, Annu. Rev. Biophys. Biomol.
Struct., 2005, 91, Palo Alto.
3 (a) P. Vlieghe, V. Lisowski, J. Martinez and M. Khrestchatisky,
Drug Discovery Today, 2010, 15, 40; (b) E. Bayer, Angew. Chem.,
Int. Ed., 1991, 30, 113; (c) E. M. Gordon, R. W. Barrett,
W. J. Dower, S. P. A. Fodor and M. A. Gallop, J. Med. Chem.,
1994, 37, 1385.
and magnetic sedimentation was investigated by turbidity
measurements (Fig. S9, ESIw). While the supports sediment in
the absence of external magnetic fields within B4 hours, a strong
magnetic field induced rapid sedimentation within B2 minutes.
Redispersion of the sedimented particles occurs upon gentle
shaking.
Ultimate proof for the applicability of colloidal supports,
however, requires the synthesis of peptides on Fe3O4@SiO2@NH-
(b-Ala)2-Rink supports. Two peptides were synthesized using
sequential assembly of Fmoc-a-amino acids, implementing
colloidal supports to standard SPPS procedures. A magnetic
sedimentation step was employed to isolate the intermediate
products after each reaction step. According to standard
SPPS, coupling reactions were facilitated by benzotriazol-
1-yl-oxytripyrrolidinophosphonium hexafluorophosphate with
N,N-diisopropyl-ethylamine in NMP. The deprotection of the
Fmoc protected a-amino groups was achieved by piperidine in
NMP. As a first model a tetrapeptide with a Phe-Lys-Leu-Gly
sequence was synthesized (Fig. 3). Liberation from the support
after peptide synthesis was performed with TFA–DCM
(50 vol%). Magnetic sedimentation of the empty supports
resulted rapidly in a colourless cleavage solution. The peptide
could be isolated by ether precipitation with B70% yields.
HPLC-ESI-MS analysis of the crude peptide exhibits remarkable
product purity of ca. 95% (Fig. 3; Fig. S14 and S15, ESIw).
Moreover, a longer undecapeptide with biological relevance
was synthesized to demonstrate the feasibility of the strategy.
The sequence Gln-Thr-Thr-Thr-Trp-Gln-Asp-Pro-Arg-Lys-Gly
as part of the hYAP WW peptide domain12 could be obtained.
MALDI-TOF-MS proved the identity of the crude peptide and
confirmed that longer sequences can be synthesized on colloidal
supports, as well (Fig. S16, ESIw). The high purity of both
peptides was in the upper range of peptides that can be obtained
on common SPPS resins. Only minor amounts of side products
could be observed, which are assignable to either deletion
sequences or stop sequences, both of which are common side
reactions to standard SPPS (Fig. S14–S16, ESIw).
4 (a) R. V. Ulijn and A. M. Smith, Chem. Soc. Rev., 2008, 37, 664;
(b) H. G. Borner, Prog. Polym. Sci., 2009, 34, 811;
¨
(c) L. Hartmann, E. Krause, M. Antonietti and H. G. Borner,
¨
Biomacromolecules, 2006, 7, 1239; (d) G. W. M. Vandermeulen and
H.-A. Klok, Macromol. Biosci., 2004, 4, 383; (e) A. Verch, H. Hahn,
E. Krause, H. Colfen and H. G. Borner, Chem. Commun., 2010,
46, 8938.
¨
¨
5 (a) D. C. Sherrington, Chem. Commun., 1998, 2275; (b) H. Becker,
H. W. Lucas, J. Maul, V. N. R. Pillai, H. Anzinger and M. Mutter,
Makromol. Chem., Rapid Commun., 1982, 3, 217.
6 (a) L. An-Hui, E. L. Salabas and F. Schuth, Angew. Chem., Int.
¨
Ed., 2007, 46, 1222; (b) I. Bilecka and M. Niederberger, Nanoscale,
2010, 2, 1358; (c) N. Pinna and M. Niederberger, Angew. Chem.,
Int. Ed., 2008, 47, 5292; (d) B. L. Cushing, V. L. Kolesnichenko
and C. J. O’Connor, Chem. Rev., 2004, 104, 3893.
7 (a) I. K. Herrmann, M. Urner, F. M. Koehler, M. Hasler, B. Roth-
Z’Graggen, R. N. Grass, U. Ziegler, B. Beck-Schimmer and
W. J. Stark, Small, 2010, 6, 1388; (b) A. H. Latham and
M. E. Williams, Acc. Chem. Res., 2008, 41, 411.
8 (a) P. Sasikumar and M. Kempe, Int. J. Pept. Res. Ther., 2007,
13, 129; (b) J. Marık, D. H. Lau, A. Song, X. Wang, R. Liu and
K. S. Lam, J. Magn. Magn. Mater., 2003, 264, 153; (c) S. Rana,
P. White and M. Bradley, Tetrahedron Lett., 1999, 40, 8137;
(d) I. Sucholeiki and J. M. Perez, Tetrahedron Lett., 1999,
40, 3531; (e) M. J. Szymonifka and K. T. Chapman, Tetrahedron
Lett., 1995, 36, 1597; (f) A. Basso, P. Braiuca, C. Ebert,
L. Gardossi and P. Linda, J. Chem. Technol. Biotechnol., 2006,
81, 1626.
9 (a) I. Bilecka, I. Djerdj and M. Niederberger, Chem. Commun.,
2008, 886; (b) I. Bilecka, M. Kubli, E. Amstad and
M. Niederberger, J. Sol-Gel Sci. Technol., 2011, 57, 313.
10 N. M. Bahadur, T. Furusawa, M. Sato, F. Kurayama,
I. A. Siddiquey and N. Suzuki, J. Colloid Interface Sci., 2010,
355, 312.
11 L. A. Carpino, Acc. Chem. Res., 1987, 20, 401.
12 (a) S. Marius, Prog. Biophys. Mol. Biol., 1996, 65, 113; (b) P. Bork
and M. Sudol, Trends Biochem. Sci., 1994, 19, 531.
c
7178 Chem. Commun., 2012, 48, 7176–7178
This journal is The Royal Society of Chemistry 2012